Literature DB >> 25296028

A new phenylpropanoid and a new isoflavone glycoside from Shenqi Fuzheng Injection.

Sheng-Yuan Zhang1, Chun-Lin Fan, Xiao-Jun Huang, Wen-Hua Huang, Xue-Hua Liu, Lei Wang, Wen-Cai Ye.   

Abstract

A new phenylpropanoid and a new isoflavone glycoside were isolated from Shenqi Fuzheng Injection. Their structures were elucidated as (αS)-α-ethenyl-4-hydroxy-3-methoxy-benzenemethanol (1) and calycosin 7-O-[α-d-glucopyranosyl (1 → 4)]-β-d-glucopyranoside (2) by means of spectroscopic methods including UV, IR, HR-ESI-MS, and NMR. The absolute configurations of 1 and 2 were confirmed by quantum chemical calculation and acid hydrolysis.

Entities:  

Keywords:  Shenqi Fuzheng Injection; isoflavone glycoside; phenylpropanoid

Mesh:

Substances:

Year:  2014        PMID: 25296028     DOI: 10.1080/10286020.2014.965161

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  1 in total

1.  Clinical efficacy and safety of Shenqi Fuzheng injection for the treatment of chronic heart failure: Protocol for a meta-analysis and systematic review.

Authors:  Chuan Wang; Dongfeng Yao; Pan Zhang; Xiaowei Xie; Bin Wang; Jiping Liu; Zhen Zhang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.